Membrane-Active Mitochondria-Targeted Antitumor Agents and Drug Delivery Systems
- 作者: Sadikov A.1, Denieva Z.2, Budanova U.1, Sebyakin Y.1
-
隶属关系:
- MIREA – Russian Technology University (Lomonosov Institute of Fine Chemical Technology)
- Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences
- 期: 卷 40, 编号 4 (2023)
- 页面: 259-272
- 栏目: ОБЗОРЫ
- URL: https://journals.rcsi.science/0233-4755/article/view/135010
- DOI: https://doi.org/10.31857/S0233475523040060
- EDN: https://elibrary.ru/OJUULY
- ID: 135010
如何引用文章
详细
Mitochondria are “power stations” of cells. Without them the normal functioning of a living cell is impossible. This organelle is an attractive target for antitumor therapy because of the variety of processes in which mitochondria are involved and the differences between mitochondria in healthy and tumor cells. In this review, various approaches to the development of diagnostic and therapeutic agents selectively directed to the mitochondria of tumor cells are described. The main mitochondrial vector ligands, their conjugation with known antitumor drugs, as well as their combination with common drug delivery systems are described.
作者简介
A. Sadikov
MIREA – Russian Technology University (Lomonosov Institute of Fine Chemical Technology)
Email: c-221@yandex.ru
Russia, 119571, Moscow
Z. Denieva
Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences
Email: c-221@yandex.ru
Russia, 119071, Moscow
U. Budanova
MIREA – Russian Technology University (Lomonosov Institute of Fine Chemical Technology)
编辑信件的主要联系方式.
Email: c-221@yandex.ru
Russia, 119571, Moscow
Yu. Sebyakin
MIREA – Russian Technology University (Lomonosov Institute of Fine Chemical Technology)
Email: c-221@yandex.ru
Russia, 119571, Moscow
参考
- Reichert A.S., Neupert W. 2004. Mitochondriomics or what makes us breathe. Trends in genetics. 20 (11), 555–562. https://doi.org/10.1016/j.tig.2004.08.012
- Cho H., Cho Y.Y., Shim M.S., Lee J.Y., Lee H.S., Kang H.C. 2020. Mitochondria-targeted drug delivery in cancers. Biochim. Biophys. Acta Mol. Basis Dis. 1866 (8), 165808. https://doi.org/10.1016/j.bbadis.2020.165808
- Buchke S., Sharma M., Bora A., Relekar M., Bhanu P., Kumar J. 2022. Mitochondria-targeted, nanoparticle-based drug-delivery systems: Therapeutics for mitochondrial disorders. Life (Basel). 12 (5), 657. https://doi.org/10.3390/life12050657
- Nelson D.L., Cox M.M. 2021. Lehninger Principles of Biochemistry. Bloomsbury Academic. 1260 p.
- Рем К.-Г., Кельман Я. 2021. Наглядная биохимия. М.: Бином, Лаборатория знаний. 512 с.
- Bleck C.K.E., Kim, Y., Willingham, T.B., Glancy, B. 2018. Subcellular connectomic analyses of energy networks in striated muscle. Nat. Commun. 9, 5111.
- Valente A.J., Fonseca J., Moradi F., Foran G., Necakov A., Stuart J.A. 2019. Quantification of mitochondrial network characteristics in health and disease. Adv. Exp. Med. Biol. 1158, 183–196. https://doi.org/10.1007/978-981-13-8367-0_10
- Белякович А.Г. 1990. Изучение митохондрий и бактерий с помощью соли тетразолия п-НТФ. ОНТИ НЦБИ АН СССР. 232 с.
- Tait S.W., Green D.R. 2013. Mitochondrial regulation of cell death. Cold Spring Harb Perspect Biol. 5 (9), a008706. https://doi.org/10.1101/cshperspect.a008706
- S Allemailem K., Almatroudi A., Alsahli M.A., Aljaghwani A., M. El-Kady A., Rahmani A.H., Khan A.A. 2021. Novel strategies for disrupting cancer-cell functions with mitochondria-targeted antitumor drug-loaded nanoformulations. Int. J. Nanomedicine. 16, 3907–3936. https://doi.org/10.2147/IJN.S303832
- Dong L., Neuzil J. 2019. Targeting mitochondria as an anticancer strategy. Cancer Commun. (Lond). 39 (1), 1–3. https://doi.org/10.1186/s40880-019-0412-6
- Reddy M.S., Bhattacharjee D., Jain N. 2022. Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis. Cell. Signalling. 92, 110279. https://doi.org/10.1016/j.cellsig.2022.110279
- Hanaford A.R., Alt J., Rais R., Wang S.Z., Kaur H., Thorek D.L.J., Eberhart C.G., Slusher B.S., Martin A.M., Raabe E.H. 2019. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Transl. Oncol. 12 (10), 1314–1322. https://doi.org/10.1016/j.tranon.2019.05.013
- Li Q., Zhong X., Yao W., Yu J., Wang C., Li Z., Lai S., Qu F., Fu X., Huang X., Zhang D., Liu Y., Li H. 2022. Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity. J. Biol. Chem. 298 (4), 101753. https://doi.org/10.1016/j.jbc.2022.101753
- Cao K., Riley J.S., Heilig R., Montes-Gómez A.E., Vringer E., Berthenet K., Cloix C., Elmasry Y., Spiller D.G., Ichim G., Campbell K.J., Gilmore A.P., Tait S.W.G. 2022. Mitochondrial dynamics regulate genome stability via control of caspase-dependent DNA damage. Dev. Cell. 57 (10), 1211–1225. https://doi.org/10.1016/j.devcel.2022.03.019
- Forrest M.D. 2015. Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapy. BioRxiv. 025197. https://doi.org/10.1101/025197
- Weiner-Gorzel K., Murphy M. 2021. Mitochondrial dynamics, a new therapeutic target for triple negative breast cancer. Biochim. Biophys. Acta (BBA) Reviews on Cancer. 1875 (2), 188518. https://doi.org/10.1016/j.bbcan.2021.188518
- Bae Y., Jung M.K., Song S.J., Green E.S., Lee S., Park H.S., Jeong S.H., Han J., Mun J.Y., Ko K.S., Choi J.S. 2017. Functional nanosome for enhanced mitochondria-targeted gene delivery and expression. Mitochondrion. 37, 27–40. https://doi.org/10.1016/j.mito.2017.06.005
- Zielonka J., Joseph J., Sikora A., Hardy M., Ouari O., Vasquez-Vivar J., Cheng G., Lopez M., Kalyanaraman B. 2017. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117 (15), 10 043–10 120. https://doi.org/10.1021/acs.chemrev.7b00042
- Murphy M.P. 1997. Selective targeting of bioactive compounds to mitochondria. Trends Biotech. 15 (8), 326–330. https://doi.org/10.1016/S0167-7799(97)01068-8
- Burns R.J., Smith R.A.J., Murphy M.P. 1995. Synthesis and characterization of thiobutyltriphenylphosphonium bromide, a novel thiol reagent targeted to the mitochondrial matrix. Arch. Biochem. Biophys. 322 (1), 60–68. https://doi.org/10.1006/abbi.1995.1436
- Burns R.J., Murphy M.P. 1997. Labeling of mitochondrial proteins in living cells by the thiol probe thiobutyltriphenylphosphonium bromide. Arch. Biochem. Biophys. 339 (1), 33–39. https://doi.org/10.1006/abbi.1996.9861
- Smith R.A., Porteous C.M., Gane A.M., Murphy M.P. 2003. Delivery of bioactive molecules to mitochondria in vivo. Proc. Nat. Acad. Sci. USA. 100 (9), 5407–5412. https://doi.org/10.1073/pnas.0931245100
- Su Y., Tu Y., Lin H., Wang M.M., Zhang G.D., Yang J., Liu H.K., Su Z. 2022. Mitochondria-targeted Pt (IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition. J. Inorg. Biochem. 226, 111653. https://doi.org/10.1016/j.jinorgbio.2021.111653
- Huang M., Myers C.R., Wang Y., You M. 2021. Mitochondria as a novel target for cancer chemoprevention: Emergence of mitochondrial-targeting agents. Cancer Prev, Res. 14 (3), 285–306. https://doi.org/10.1158/1940-6207.CAPR-20-0425
- Bailly C. 2021. Medicinal applications and molecular targets of dequalinium chloride. Biochem. Pharmacol. 186, 114467. https://doi.org/10.1016/j.bcp.2021.114467
- Shi M., Zhang J., Li X., Pan S., Li J., Yang C., Hu H., Qiao M., Chen D., Zhao X. 2018. Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes. Int. J. Nanomedicine. 13, 4209–4226. https://doi.org/10.2147/IJN.S163858
- Bailly C. 2021. Medicinal applications and molecular targets of dequalinium chloride. Biochem. Pharmacol. 186, 114467. https://doi.org/10.1016/j.bcp.2021.114467
- Mallick S., Thuy L.T., Lee S., Park J.I., Choi J.S. 2018. Liposomes containing cholesterol and mitochondria-penetrating peptide (MPP) for targeted delivery of antimycin A to A549 cells. Colloids Surf. B. Biointerfaces. 161, 356–364. https://doi.org/10.1016/j.colsurfb.2017.10.052
- Somsri S., Mungthin M., Klubthawee N., Adisakwattana P., Hanpithakpong W., Aunpad R.A. 2021. Mitochondria-penetrating peptide exerts potent anti-plasmodium activity and localizes at parasites’ mitochondria. Antibiotics (Basel). 10 (12), 1560. https://doi.org/10.3390/antibiotics10121560
- Szeto H.H. 2006. Cell-permeable, mitochondrial-targeted, peptide antioxidants. The AAPS J. 8 (2), E277–E283. https://doi.org/10.1007/BF02854898
- Szeto H.H., Schiller P.W. 2011. Novel therapies targeting inner mitochondrial membrane–from discovery to clinical development. Pharm Res. 28 (11), 2669–2679. https://doi.org/10.1007/s11095-011-0476-8
- Haftcheshmeh S.M., Jaafari M.R, Mashreghi M., Mehrabian A., Alavizadeh S.H, Zamani P., Zarqi J., Darvishi M.H., Gheybi F. 2021. Liposomal doxorubicin targeting mitochondria: A novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo. J. Drug Delivery Sci.Technol. 62, 102351. https://doi.org/10.1016/j.jddst.2021.102351
- Bae Y., Kim G., Jessa F., Ko K.S., Han J. 2022. Gallic acid-mitochondria targeting sequence-H3R9 induces mitochondria-targeted cytoprotection. Korean J. Physiol. Pharmacol. 26, 15–24. https://doi.org/10.4196/kjpp.2022.26.1.15
- Tee T.T., Cheah Y.H., Hawariah L.P. 2007. F16, a fraction from Eurycoma longifolia jack extract, induces apoptosis via a caspase-9-independent manner in MCF-7 cells. Anticancer Res. 27 (5A), 3425–3430.
- Dubinin M.V., Semenova A.A., Nedopekina D.A., Davletshin E.V., Spivak A.Y., Belosludtsev K.N. 2021. Effect of F16-betulin conjugate on mitochondrial membranes and its role in cell death initiation. Membranes. 11 (5), 352. https://doi.org/10.3390/membranes11050352
- Dubinin M.V., Semenova A.A., Ilzorkina A.I., Penkov N.V., Nedopekina D.A., Sharapov V.A., Khoroshavina E.I., Davletshin E.V., Belosludtseva N.V., Spivak A.Y., Belosludtsev K.N. 2021. Mitochondria-targeted prooxidant effects of betulinic acid conjugated with delocalized lipophilic cation F16. Free Radic. Biol. Med. 168, 55–69. https://doi.org/10.1016/j.freeradbiomed.2021.03.036
- Watley R.L., Awuah S.G., Bio M., Cantu R., Gobeze H.B., Nesterov V.N., Das S.K., D’Souza F., You Y. 2015. Dual functioning thieno-pyrrole fused BODIPY dyes for NIR optical imaging and photodynamic therapy: Singlet oxygen generation without heavy halogen atom assistance. Chem. Asian J. 10, 1335–1343. https://doi.org/10.1002/asia.201500140
- Belosludtsev K.N., Ilzorkina A.I., Belosludtseva N.V., Sharapov V.A., Penkov N.V., Serov D.A., Karagyaur M.N., Nedopekina D.A., Davletshin E.V., Solovieva M.E., Spivak A.Y., Kuzmina U.S., Vakhitova Y.V., Akatov V.S., Dubinin M.V. 2022. Comparative study of cytotoxic and membranotropic properties of betulinic acid-F16 conjugate on breast adenocarcinoma cells (MCF-7) and primary human fibroblasts. Biomedicines. 10 (11), 2903. https://doi.org/10.3390/biomedicines10112903
- Zhang D., Wen L., Huang R., Wang H., Hu X., Xing D. 2018. Mitochondrial specific photodynamic therapy by rare-earth nanoparticles mediated near-infrared graphene quantum dots. Biomaterials. 153, 14–26. https://doi.org/10.1016/j.biomaterials.2017.10.034
- Khailova L.S,. Silachev D.N., Rokitskaya T.I., Avetisyan A.V., Lyamsaev K.G., Severina I.I., Il’yasova T.M., Gulyaev M.V., Dedukhova V.I., Trendeleva T.A., Plotnikov E.Y., Zvyagilskaya R.A., Chernyak B.V., Zorov D.B., Antonenko Y.N., Skulachev V.P. 2014. A short-chain alkyl derivative of Rhodamine 19 acts as a mild uncoupler of mitochondria and a neuroprotector. Biochim. et Biophys. Acta (BBA) – Bioenerget. 1837 (10), 1739–1747. https://doi.org/10.1016/j.bbabio.2014.07.006
- Lei E.K., Kelley S.O. 2017. Delivery and release of small-molecule probes in mitochondria using traceless linkers. J. Amer. Chem. Soc. 139 (28), 9455–9458. https://doi.org/10.1021/jacs.7b04415
- Ripcke J., Zarse K., Ristow M., Birringer M. 2009. Small-molecule targeting of the mitochondrial compartment with an endogenously cleaved reversible tag. ChemBioChem. 10.(10), 1689–1696. https://doi.org/10.1002/cbic.200900159
- Pathak R.K., Marrache S., Harn D.A., Dhar S. 2014. Mito-DCA: A mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. ACS Chem. Biol. 9 (5), 1178–1187. https://doi.org/10.1021/cb400944y
- Battogtokh G., Choi Y.S., Kang D.S., Park S.J., Shim M.S., Huh K.M., Kang H.C. 2018. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Acta Pharmaceutica Sinica B. 8 (6), 862–880. https://doi.org/10.1016/j.apsb.2018.05.006
- Dubinin M.V., Semenova A.A., Ilzorkina A.I., Penkov N.V., Nedopekina D.A., Sharapov V.A., Khoroshavina E.I., Davletshin E.V., Belosludtseva N.V., Spivak A.Yu, Belosludtsev K.N. 2021. Mitochondria-targeted prooxidant effects of betulinic acid conjugated with delocalized lipophilic cation F1. Free Radical Biol. and Medicine. 168, 55–69. https://doi.org/10.1016/j.freeradbiomed.2021.03.036
- Mojarad-Jabali S., Farshbaf M., Walker P.R., Hemmati S., Fatahi Y., Zakeri-Milani P., Sarfraz M., Valizadeh H. 2021. An update on actively targeted liposomes in advanced drug delivery to glioma. Int. J. Pharmaceutics. 602, 120645. https://doi.org/10.1016/j.ijpharm.2021.120645
- Turetskiy E.A., Koloskova O.O., Nosova A.S., Shilovskiy I.P., Sebyakin Y.L., Khaitov M.R. 2017. Physicochemical properties of lipopeptide-based liposomes and their complexes with siRNA. Biomed. Khim. 63 (5), 472–475. Russian. https://doi.org/10.18097/PBMC20176305472
- Liu P., Chen G., Zhang J. 2022. A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules. 27 (4), 1372. https://doi.org/10.3390/molecules27041372
- Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., Yamashita K., Kobayashi H., Kikuchi H., Harashima H. 2008. MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. et Biophys. Acta (BBA)-Biomembranes. 1778 (2), 423–432. https://doi.org/10.1016/j.bbamem.2007.11.002
- Yamada Y., Nakamura K., Abe J., Hyodo M., Haga S., Ozaki M., Harashima H. 2015. Mitochondrial delivery of coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver. J. Control. Release. 213, 86–95. https://doi.org/10.1016/j.jconrel.2015.06.037
- Yamada Y., Tabata M., Yasuzaki Y., Nomura M., Shibata A., Ibayashi Y., Taniguchi Y., Sasaki S., Harashima H. 2014. A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials. 35 (24), 6430–6438. https://doi.org/10.1016/j.biomaterials.2014.04.017
- Yamada Y., Maruyama M., Kita T., Usami S.I., Kitajiri S.I., Harashima H. 2020. The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease’s cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activity. Mitochondrion. 55, 134–144. https://doi.org/10.1016/j.mito.2020.09.008
- Lu J., Li R., Mu B., Peng Y., Zhao Y., Shi Y., Guo L., Hai L., Wu Y. 2022. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma. Eur. J. Med. Chem. 230, 114093. https://doi.org/10.1016/j.ejmech.2021.114093
- Thomas A.P., Lee A.J., Palanikumar L, Jana B., Kim K., Kim S., Ok H., Seol J., Kim D., Kang B.H., Ryu J.H. 2019. Mitochondrial heat shock protein-guided photodynamic therapy. Chem. Commun. (Camb.). 55 (84), 12 631–12 634. https://doi.org/10.1039/c9cc06411g
- Jiang L., Zhou S., Zhang X., Li C., Ji S., Mao H., Jiang X. 2021. Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery. Nature Comm. 12, 2390. https://doi.org/10.1038/s41467-021-22594-2
- Cao Z., Zhu W., Wang W., Zhang C., Xu M., Liu J., Feng S.T., Jiang Q., Xie X. 2014. Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging. Int. J. Nanomedicine. 9, 5103–5116. https://doi.org/10.2147/IJN.S66919
- Gileva A., Sarychev G., Kondrya U., Mironova M., Sapach A., Selina O., Budanova U., Burov S., Sebyakin Y., Markvicheva E. 2019. Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation. Mater. Sci. Eng. C Mater. Biol. Appl. 100, 724–734. https://doi.org/10.1016/j.msec.2019.02.111
- Wang Y., Wang B., Liao H., Song X., Wu H., Wang H., Shen H., Ma X., Tan M. 2015. Liposomal nanohybrid cerasomes for mitochondria-targeted drug delivery. J. Mater. Chem. B. 3 (36), 7291–7299. https://doi.org/10.1039/c5tb01197c
- Damrongrak K., Kloysawat K., Bunsupa S., Sakchasri K., Wongrakpanich A., Taresco V., Cuzzucoli Crucitti V., Garnett M.C., Suksiriworapong J. 2022. Delivery of acetogenin-enriched Annona muricata Linn leaf extract by folic acid-conjugated and triphenylphosphonium-conjugated poly (glycerol adipate) nanoparticles to enhance toxicity against ovarian cancer cells. Int. J. Pharm. 618, 121636. https://doi.org/10.1016/j.ijpharm.2022.121636
- Wang Z., Sun C., Wu H., Xie J., Zhang T., Li Y., Xu X., Wang P., Wang C. 2021. Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer. Mater. Today Bio. 13, 100189. https://doi.org/10.1016/j.mtbio.2021.100189
- Wang H., Zhang F., Wen H., Shi W., Huang Q., Huang Y., Xie J., Li P., Chen J, Qin L., Zhou Y. 2020. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis. J. Nanobiotechnol. 18 (1), 8. https://doi.org/10.1186/s12951-019-0562-3
- Xu Y., Wang S., Chan H.F., Liu Y., Li H., He C., Li Z., Chen M. 2017. Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria-targeted gambogic acid delivery. Int. J. Pharm. 522 (1–2), 21–33. https://doi.org/10.1016/j.ijpharm.2017.01.064
- Wang J., Li B., Qiu L., Qiao X., Yang H. 2022. Dendrimer-based drug delivery systems: History, challenges, and latest developments. J. Biol. Eng. 16 (1), 18. https://doi.org/10.1186/s13036-022-00298-5
- Liang S., Sun C., Yang P., Ma P., Huang S., Cheng Z., Yu X., Lin J. 2020. Core-shell structured upconversion nanocrystal-dendrimer composite as a carrier for mitochondria targeting and catalase enhanced anti-cancer photodynamic therapy. Biomaterials. 240, 119850. https://doi.org/10.1016/j.biomaterials.2020.119850
- Johnson L.V., Walsh M.L., Chen L.B. 1980. Localization of mitochondria in living cells with rhodamine 123. Proc. Nat. Acad. Sci. USA. 77 (2), 990–994. https://doi.org/10.1073/pnas.77.2.990
- Summerhayes I.C., Lampidis T.J., Bernal S.D., Nadakavukaren J.J., Nadakavukaren KK, Shepherd E.L., Chen L.B. 1982. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Nat. Acad. Sci. USA. 79 (17), 5292–5296. https://doi.org/10.1073/pnas.79.17.5292